Wells Fargo Securities Healthcare Conference. Susan M. Molineaux, Ph.D, the company’s Founder, President and Chief Executive Officer, will present in Bostonon Thursday, September 8, at 1:45 p.m. Eastern Time.
- BioCentury 23rd Annual NewsMakers in the
Biotech Industry Conference. Susan M. Molineaux, Ph.D, the company’s Founder, President and Chief Executive Officer, will present in New Yorkon Friday, September 9, at 3:00 p.m. Eastern Time.
About Calithera Biosciences
Forward Looking Statements
Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "anticipate," "estimate," "intend," "poised" and similar expressions (as well as other words or expressions referencing future events, conditions, or circumstances) are intended to identify forward-looking statements. These statements include those related to the safety, tolerability and efficacy of CB-839, enrollment of the combination expansion cohorts of CB-839 and the presentation of additional combination data in 2016. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. The potential product candidates that Calithera develops may not progress through clinical development or receive required regulatory approvals within expected timelines or at all. In addition, clinical trials may not confirm any safety, potency or other product characteristics described or assumed in this press release. Such product candidates may not be beneficial to patients or successfully commercialized. The failure to meet expectations with respect to any of the foregoing matters may have a negative effect on Calithera's stock price. Additional information concerning these and other risk factors affecting Calithera's business can be found in Calithera's most recent Quarterly Report on Form 10-Q filed with the
Jennifer McNealeyir@Calithera.com 650-870-1071